Explore our 🎯 Q1 2026 Psychedelic Pipeline Bullseye Charts.

Psychedelic Bulletin #158: Fluence Brings Psychedelic Therapy Training to Ukraine; MindBio’s Microdosing Readout; Biomind’s 5-MeO-DMT Study; and more…

Pα+

Pα+ Psychedelic Bulletin #158: Fluence Brings Psychedelic Therapy Training to Ukraine; MindBio’s Microdosing Readout; Biomind’s 5-MeO-DMT Study; and more…

  • Fluence and UPRA Team Up to Bring Psychedelic Therapy Training to Ukraine
  • MindBio’s Small Open Label Microdosing Study Shows Promise in MDD
  • Biomind’s 5-MeO-DMT Study Shows Promise, But Small Sample and Unclear Protocol Temper Excitement
  • Oregon Psilocybin Services Complaints
  • Other News

Companies, organisations and drug candidates mentioned in this Bulletin: Fluence, Ukrainian Psychedelic Research Association, Heal Ukraine Trauma, MAPS, MindBio, MB22001, Biomind, BMND08, atai Life Sciences; VLS-01; Nue Life Health.

Join Today

Independent data-driven reporting, analysis and commentary on the psychedelics space: from business and drug development through to policy reform and research.

Monthly $20 Annually $200
  • Regular Bulletins featuring news, analysis, and research
  • Articles and deep dives across psychedelic drug development, policy, and research
  • Exclusive interviews with researchers, executives, and policymakers
  • Bespoke resources and tools including the Psychedelic Bill Tracker
  • Quarterly video briefings and slide decks

Join Today

Independent data-driven reporting, analysis and commentary on the psychedelics space: from business and drug development through to policy reform and research.

Monthly $20 Annually $200

Subscribe to our
free newsletter


By signing up, you agree to our privacy policy. You can unsubscribe at any time.

Learn More About

Group, team &
corporate plans


Aside from group pricing, we also offer bespoke reports and regular briefings. Get in touch to discuss.